Press Release Medical Technology/Oncology 1 min read

Aussie medtech Ferronova raises another $6 million to advance image-guided cancer surgery

Australian medical technology company Ferronova has raised an additional $6 million in a Series A extension round led by existing investors to advance clinical trials and commercialization of its nanoparticle image-guided surgery technology for stomach and oesophageal cancers.

Uniseed/UniSuper South Australian Venture Capital Fund Artesian Venture Partners Renew Pharmaceuticals Ferronova UltraGreen.ai University of South Australia Powerhouse Ventures University of Wellington University of Sydney PAN Ventures STOIC Venture Capital Perennial Partners Future of HealthCare Fund
Press ReleaseDecember 17, 2025
Uniseed/UniSuper

Australian medical technology company Ferronova has raised an additional $6 million in a Series A extension round led by existing investors to advance clinical trials and commercialization of its nanoparticle image-guided surgery technology for stomach and oesophageal cancers.

Related articles

Press ReleaseSeptember 16, 2026
ASSA ABLOY

ASSA ABLOY acquires PACLOCK in the US

September 16, 2026
Press ReleaseSeptember 16, 2026
MySize

MySize Announces $2.5 Million Private Placement Priced At-the-Market Under Nasdaq Rules

September 16, 2026
Press ReleaseSeptember 16, 2026
Xpansiv

Xpansiv to Acquire Formbay, Australia's AI-Enabled Renewable Energy Certificate and Compliance Technology Platform

September 16, 2026
← Back to all articles

Generated by Olivia 6